Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature

J Infect Dev Ctries. 2024 Mar 31;18(3):480-487. doi: 10.3855/jidc.18868.

Abstract

Introduction: Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application.

Case presentations: In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.

Results: The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.

Conclusions: Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.

Keywords: antitoxin; botulinum toxin; botulism; iatrogenic.

Publication types

  • Review

MeSH terms

  • Botulinum Antitoxin / therapeutic use
  • Botulinum Toxins* / therapeutic use
  • Botulinum Toxins, Type A* / adverse effects
  • Botulism* / diagnosis
  • Botulism* / drug therapy
  • Botulism* / etiology
  • Clostridium botulinum*
  • Humans
  • Iatrogenic Disease
  • Paralysis / complications
  • Paralysis / drug therapy

Substances

  • Botulinum Toxins
  • Botulinum Antitoxin
  • Botulinum Toxins, Type A